parecoxib has been researched along with docosahexaenoate in 2 studies
| Studies (parecoxib) | Trials (parecoxib) | Recent Studies (post-2010) (parecoxib) | Studies (docosahexaenoate) | Trials (docosahexaenoate) | Recent Studies (post-2010) (docosahexaenoate) |
|---|---|---|---|---|---|
| 436 | 186 | 229 | 48 | 1 | 28 |
| Protein | Taxonomy | parecoxib (IC50) | docosahexaenoate (IC50) |
|---|---|---|---|
| Caspase-1 | Homo sapiens (human) | 6.76 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 9.8 | |
| Oxoeicosanoid receptor 1 | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heitel, P; Kalinowsky, L; Merk, D; Proschak, E | 1 |
| Merk, D; Willems, S | 1 |
2 review(s) available for parecoxib and docosahexaenoate
| Article | Year |
|---|---|
Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery.
Topics: Animals; Cyclooxygenase Inhibitors; Drug Discovery; Fatty Acids; Humans; Inflammation; Models, Molecular | 2017 |
Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration.
Topics: Chemistry, Pharmaceutical; Humans; Ligands; Nuclear Receptor Subfamily 4, Group A, Member 2; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2022 |